BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8865163)

  • 1. Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells.
    el-Tanani MK; Green CD
    Mol Cell Endocrinol; 1996 Jul; 121(1):29-35. PubMed ID: 8865163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between estradiol and cAMP in the regulation of specific gene expression.
    el-Tanani MK; Green CD
    Mol Cell Endocrinol; 1996 Nov; 124(1-2):71-7. PubMed ID: 9027326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
    Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
    J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells.
    El-Tanani MK; Green CD
    J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):269-76. PubMed ID: 9219917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells.
    Cavailles V; Garcia M; Rochefort H
    Mol Endocrinol; 1989 Mar; 3(3):552-8. PubMed ID: 2664475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
    Rajah TT; Dunn ST; Pento JT
    Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.
    Huber M; Poulin R
    J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1.
    Wang DY; Fulthorpe R; Liss SN; Edwards EA
    Mol Endocrinol; 2004 Feb; 18(2):402-11. PubMed ID: 14605097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
    Aronica SM; Katzenellenbogen BS
    Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway.
    Inadera H
    Biochem Biophys Res Commun; 2003 Sep; 309(2):272-8. PubMed ID: 12951045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines.
    Martínez-Lacaci I; Saceda M; Plowman GD; Johnson GR; Normanno N; Salomon DS; Dickson RB
    Endocrinology; 1995 Sep; 136(9):3983-92. PubMed ID: 7649107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal regulation of FHG22 mRNA in Syrian hamster harderian glands: role of estradiol.
    Varriale B; Alvarez J; Prieto F; Domínguez P
    Mol Cell Endocrinol; 1996 Nov; 124(1-2):87-96. PubMed ID: 9027328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.